九年前，莉萨·海恩斯（Lisa Haines）悲观地得知，她之前通过化疗抑制的肺癌又复发了。正当这名患者准备接受现实，主治医生推荐了一种免疫疗法，Opdivo。

A large “de-escalation” trial suggests that tens of thousands of people annually may be able to rely on only chemotherapy and surgery to treat their illness. By Gina Kolata For some patients ...

But within its labs Organon had developed a little-noticed PD1-targeting antibody it called lambrolizumab. By the time Merck absorbed Organon, lambrolizumab wasn’t a high priority and, according to ...

Abstract CRA9006, ASCO 2013. 2. Ribas et al., 2013. Clinical efficacy and safety of lambrolizumab (MK-3475, Anti-PD-1 monoclonal antibody) in patients with advanced melanoma. Abstract 9009 ...